Secondary cytoreduction

PROCEDURE2 trials

Sponsors

Women's Hospital School Of Medicine Zhejiang University, Fudan University

Conditions

Ovarian CancerRelapsed Ovarian Cancer

Phase 2

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

Not yet recruitingNCT06544460

Fudan UniversityOvarian Cancer

Start: 2024-08-31End: 2026-12-31Target: 94Updated: 2024-08-09

Unknown Phase

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

RecruitingNCT05607329

Women's Hospital School Of Medicine Zhejiang UniversityRelapsed Ovarian Cancer

Start: 2021-05-01End: 2028-05-01Target: 400Updated: 2022-11-07

Related Papers

Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trial.

2024-02-055 citations